バイオスラックス(炭疽菌ワクチン)の世界市場2021-2026:生ワクチン、無細胞PAワクチン

LP Informationが発行した調査報告書(LPI21JL16471)
◆英語タイトル:Global Biothrax (Anthrax Vaccine) Market Growth 2021-2026
◆商品コード:LPI21JL16471
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:181
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LP Information社の「バイオスラックス(炭疽菌ワクチン)の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、生ワクチン、無細胞PAワクチンなど、用途別には、ヒト用、動物用などにセグメント区分してまとめました。バイオスラックス(炭疽菌ワクチン)のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・バイオスラックス(炭疽菌ワクチン)の世界市場概要(サマリー)
・バイオスラックス(炭疽菌ワクチン)の企業別販売量・売上
・バイオスラックス(炭疽菌ワクチン)の企業別市場シェア
・バイオスラックス(炭疽菌ワクチン)の世界市場規模 2016年-2021年:種類別(生ワクチン、無細胞PAワクチン)
・バイオスラックス(炭疽菌ワクチン)の世界市場規模 2016年-2021年:用途別(ヒト用、動物用)
・バイオスラックス(炭疽菌ワクチン)の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・バイオスラックス(炭疽菌ワクチン)のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・バイオスラックス(炭疽菌ワクチン)のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・バイオスラックス(炭疽菌ワクチン)の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・バイオスラックス(炭疽菌ワクチン)市場の成長要因・課題・動向
・バイオスラックス(炭疽菌ワクチン)の世界市場予測 2021年-2026年
・バイオスラックス(炭疽菌ワクチン)の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・バイオスラックス(炭疽菌ワクチン)のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・バイオスラックス(炭疽菌ワクチン)のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・バイオスラックス(炭疽菌ワクチン)の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・バイオスラックス(炭疽菌ワクチン)の世界市場予測:種類別(生ワクチン、無細胞PAワクチン)
・バイオスラックス(炭疽菌ワクチン)の世界市場予測:用途別(ヒト用、動物用)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Biothrax (Anthrax Vaccine) will have significant change from previous year. By the most conservative estimates of global Biothrax (Anthrax Vaccine) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Biothrax (Anthrax Vaccine) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Biothrax (Anthrax Vaccine) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live Vaccines
Cell Free PA Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Human Use
Animal Use

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Consumption 2016-2026
2.1.2 Biothrax (Anthrax Vaccine) Consumption CAGR by Region
2.2 Biothrax (Anthrax Vaccine) Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell Free PA Vaccines
2.3 Biothrax (Anthrax Vaccine) Sales by Type
2.3.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2021)
2.3.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Type (2016-2021)
2.4 Biothrax (Anthrax Vaccine) Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Biothrax (Anthrax Vaccine) Sales by Application
2.5.1 Global Biothrax (Anthrax Vaccine) Sale Market Share by Application (2016-2021)
2.5.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Biothrax (Anthrax Vaccine) Sale Price by Application (2016-2021)

3 Global Biothrax (Anthrax Vaccine) by Company
3.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Company
3.1.1 Global Biothrax (Anthrax Vaccine) Sales by Company (2019-2021)
3.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Company (2019-2021)
3.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company
3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Company (2019-2021)
3.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Company (2019-2021)
3.3 Global Biothrax (Anthrax Vaccine) Sale Price by Company
3.4 Global Manufacturers Biothrax (Anthrax Vaccine) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biothrax (Anthrax Vaccine) Product Location Distribution
3.4.2 Players Biothrax (Anthrax Vaccine) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biothrax (Anthrax Vaccine) by Region
4.1 Global Biothrax (Anthrax Vaccine) by Region
4.1.1 Global Biothrax (Anthrax Vaccine) Sales by Region
4.1.2 Global Biothrax (Anthrax Vaccine) Revenue by Region
4.2 Americas Biothrax (Anthrax Vaccine) Sales Growth
4.3 APAC Biothrax (Anthrax Vaccine) Sales Growth
4.4 Europe Biothrax (Anthrax Vaccine) Sales Growth
4.5 Middle East & Africa Biothrax (Anthrax Vaccine) Sales Growth

5 Americas
5.1 Americas Biothrax (Anthrax Vaccine) Sales by Country
5.1.1 Americas Biothrax (Anthrax Vaccine) Sales by Country (2016-2021)
5.1.2 Americas Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021)
5.2 Americas Biothrax (Anthrax Vaccine) Sales by Type
5.3 Americas Biothrax (Anthrax Vaccine) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Biothrax (Anthrax Vaccine) Sales by Region
6.1.1 APAC Biothrax (Anthrax Vaccine) Sales by Region (2016-2021)
6.1.2 APAC Biothrax (Anthrax Vaccine) Revenue by Region (2016-2021)
6.2 APAC Biothrax (Anthrax Vaccine) Sales by Type
6.3 APAC Biothrax (Anthrax Vaccine) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Biothrax (Anthrax Vaccine) by Country
7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Country (2016-2021)
7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021)
7.2 Europe Biothrax (Anthrax Vaccine) Sales by Type
7.3 Europe Biothrax (Anthrax Vaccine) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Biothrax (Anthrax Vaccine) by Country
8.1.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021)
8.2 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Type
8.3 Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biothrax (Anthrax Vaccine) Distributors
10.3 Biothrax (Anthrax Vaccine) Customer

11 Global Biothrax (Anthrax Vaccine) Market Forecast
11.1 Global Biothrax (Anthrax Vaccine) Forecast by Region
11.1.1 Global Biothrax (Anthrax Vaccine) Forecast by Regions (2021-2026)
11.2.2 Global Biothrax (Anthrax Vaccine) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Biothrax (Anthrax Vaccine) Forecast by Type
11.7 Global Biothrax (Anthrax Vaccine) Forecast by Application

12 Key Players Analysis
12.1 Merial
12.1.1 Merial Merial Company Information
12.1.2 Merial Biothrax (Anthrax Vaccine) Product Offered
12.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merial Main Business Overview
12.1.5 Merial Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Biothrax (Anthrax Vaccine) Product Offered
12.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Zoetis
12.3.1 Zoetis Company Information
12.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Offered
12.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Zoetis Main Business Overview
12.3.5 Zoetis Latest Developments
12.4 Bayer Sanidad Animal
12.4.1 Bayer Sanidad Animal Company Information
12.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Offered
12.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Bayer Sanidad Animal Main Business Overview
12.4.5 Bayer Sanidad Animal Latest Developments
12.5 Colorado Serum
12.5.1 Colorado Serum Company Information
12.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Offered
12.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Colorado Serum Main Business Overview
12.5.5 Colorado Serum Latest Developments
12.6 PharmAthene
12.6.1 PharmAthene Company Information
12.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Offered
12.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 PharmAthene Main Business Overview
12.6.5 PharmAthene Latest Developments
12.7 Tiankang
12.7.1 Tiankang Company Information
12.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Offered
12.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Tiankang Main Business Overview
12.7.5 Tiankang Latest Developments
12.8 Biogénesis-Bago
12.8.1 Biogénesis-Bago Company Information
12.8.2 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Offered
12.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Biogénesis-Bago Main Business Overview
12.8.5 Biogénesis-Bago Latest Developments
12.9 CAVAC
12.9.1 CAVAC Company Information
12.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Offered
12.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 CAVAC Main Business Overview
12.9.5 CAVAC Latest Developments
12.10 Rosenbusch
12.10.1 Rosenbusch Company Information
12.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Offered
12.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Rosenbusch Main Business Overview
12.10.5 Rosenbusch Latest Developments
12.11 Agrovet
12.11.1 Agrovet Company Information
12.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Offered
12.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Agrovet Main Business Overview
12.11.5 Agrovet Latest Developments
12.12 Vecol
12.12.1 Vecol Company Information
12.12.2 Vecol Biothrax (Anthrax Vaccine) Product Offered
12.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Vecol Main Business Overview
12.12.5 Vecol Latest Developments
12.13 CVCRI
12.13.1 CVCRI Company Information
12.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Offered
12.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 CVCRI Main Business Overview
12.13.5 CVCRI Latest Developments
12.14 IVPM
12.14.1 IVPM Company Information
12.14.2 IVPM Biothrax (Anthrax Vaccine) Product Offered
12.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 IVPM Main Business Overview
12.14.5 IVPM Latest Developments
12.15 Prondil
12.15.1 Prondil Company Information
12.15.2 Prondil Biothrax (Anthrax Vaccine) Product Offered
12.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Prondil Main Business Overview
12.15.5 Prondil Latest Developments
12.16 CDV
12.16.1 CDV Company Information
12.16.2 CDV Biothrax (Anthrax Vaccine) Product Offered
12.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 CDV Main Business Overview
12.16.5 CDV Latest Developments
12.17 Indian Immunologicals
12.17.1 Indian Immunologicals Company Information
12.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Offered
12.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Indian Immunologicals Main Business Overview
12.17.5 Indian Immunologicals Latest Developments
12.18 Botswana Vaccine Institute
12.18.1 Botswana Vaccine Institute Company Information
12.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Offered
12.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Botswana Vaccine Institute Main Business Overview
12.18.5 Botswana Vaccine Institute Latest Developments
12.19 Ceva Santé Animale
12.19.1 Ceva Santé Animale Company Information
12.19.2 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Offered
12.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Ceva Santé Animale Main Business Overview
12.19.5 Ceva Santé Animale Latest Developments
12.20 Intervac
12.20.1 Intervac Company Information
12.20.2 Intervac Biothrax (Anthrax Vaccine) Product Offered
12.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Intervac Main Business Overview
12.20.5 Intervac Latest Developments
12.21 JOVAC
12.21.1 JOVAC Company Information
12.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Offered
12.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 JOVAC Main Business Overview
12.21.5 JOVAC Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ バイオスラックス(炭疽菌ワクチン)の世界市場2021-2026:生ワクチン、無細胞PAワクチン(Global Biothrax (Anthrax Vaccine) Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。